OverviewChartNewsTraderScreen

Longboard Pharmaceuticals/  US54300N1037  /

IEX
2024-05-07  9:59:56 PM Chg. +1.46 Volume Bid- Ask- High Low
22.07USD +7.08% 9,330
Turnover: 201,610.27		 -Bid Size: - -Ask Size: - 22.48 20.47
GlobeNewswire 02-21 AdhereTech Announces Appointment of Paul Sekhri to Board of Directors
GlobeNewswire 2022-03-24 TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Busines...
GlobeNewswire 2022-03-23 Longboard Pharmaceuticals to Participate in Cantor Fitzgerald’s Virtual Rare Orphan Disease Summit
GlobeNewswire 2022-03-22 Longboard Pharmaceuticals to Participate in Maxim Group 2022 Virtual Growth Conference
GlobeNewswire 2022-03-21 Longboard Pharmaceuticals Announces the Appointment of Highly Accomplished Healthcare Executive Rand...
GlobeNewswire 2022-03-03 Longboard Pharmaceuticals Provides Corporate Update and Reports Full Year 2021 Financial Results
GlobeNewswire 2022-01-05 Longboard Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference
GlobeNewswire 2021-11-17 Longboard Pharmaceuticals Appoints Life Sciences Executive Dr. Jane Tiller to Board of Directors
GlobeNewswire 2021-11-11 Longboard Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire 2021-11-04 Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results
GlobeNewswire 2021-11-02 Longboard Pharmaceuticals Announces Steven W. Spector Joins the Company as General Counsel
GlobeNewswire 2021-09-21 Longboard Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference on September...
GlobeNewswire 2021-09-08 Longboard Pharmaceuticals Successfully Completes LP352 Multiple Ascending Dose Portion of Phase 1 Cl...
GlobeNewswire 2021-08-31 Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences
GlobeNewswire 2021-08-09 Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial Result...
GlobeNewswire 2021-05-10 Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2021 Financial Results
GlobeNewswire 2021-03-12 Longboard Pharmaceuticals Announces Pricing of Initial Public Offering
GlobeNewswire 2021-01-21 Longboard Pharmaceuticals Appoints Brandi L. Roberts as Chief Financial Officer
GlobeNewswire 2021-01-20 Longboard Pharmaceuticals Appoints Phillip Schneider and Paul Sekhri to Board of Directors